Dr. Dean Eliott, M.D., serves on the Aldeyra Therapeutics Retina Scientific Advisory Board. He is the Stelios Evangelos Gragoudas Associate Professor of Ophthalmology at Harvard Medical School, Director of the Retina Service at Massachusetts Eye and Ear Infirmary, Director of the Retina Fellowship at Harvard/Mass. Eye and Ear, and Co-Founder of Helio Vision. Dr. Eliott enjoys a national reputation as a talented vitreoretinal surgeon and is sought by colleagues for difficult surgical cases. He is especially interested in treating retinal detachment, proliferative vitreoretinopathy, diabetic retinopathy, eye trauma, and complex vitreoretinal surgical problems.
Dr. Eliott received his undergraduate degree with honors from Duke University, and he received his medical degree with honors from Vanderbilt University School of Medicine. He completed his residency at the highly regarded Wilmer Eye Institute of Johns Hopkins Hospital. He received his retina fellowship training at the Duke Eye Center of Duke University Medical Center, working with Dr. Robert Machemer, who is considered the father of modern vitreous surgery for performing the first vitrectomy. Dr. Eliott then served as Chief Resident and retina faculty member at the Duke Eye Center.
Following this, Dr. Eliott was the Director of the Retina Service, Associate Professor, and Retina Fellowship Director at the Kresge Eye Institute of Wayne State University School of Medicine. Subsequently, he was the Director of the Doheny Retina Institute, Professor, and Retina Fellowship Director at the Doheny Eye Institute of the University of Southern California Keck School of Medicine.